AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.052

-0.004-7.14%

Volume:21.75M

Turnover:1.18M

Market Cap:115.34M

PE:-1.11

High:0.056

Open:0.056

Low:0.052

Close:0.056

52wk High:0.485

52wk Low:0.052

Shares:2.22B

Float Shares:1.72B

Volume Ratio:1.68

T/O Rate:1.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.047

EPS(LYR):-0.047

ROE:-121.11%

ROA:-53.68%

PB:2.14

PE(LYR):-1.11

Loading ...

Overview Company News Filings

BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million

Botanix Pharmaceuticals Ltd - Revenue From Ordinary Activities for Hy a$16.5 Mln

THOMSON REUTERS

Bank of Thailand Unexpectedly Cuts Rate to 1% in Second Consecutive Easing Measure

A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings

Simply Wall St.

Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low

MT Newswires Live

BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement

Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share

THOMSON REUTERS

Danantara Names Five Chinese Finalists for Waste-to-Energy Projects

BRIEF-Botanix Pharmaceuticals Requests Trading Halt

Botanix Pharmaceuticals Ltd - Requests Trading Halt for Potential Capital Raising

THOMSON REUTERS

Blue Ocean Technologies Announces Executive Changes

NetAssist Strengthens SOC Capabilities with Graylog Security

Indonesia Joins Nexus Project to Strengthen Cross-Border Payments

Botanix Pharmaceuticals Hosts Quarterly Update Webinar

ASX Penny Stocks Spotlight: Botanix Pharmaceuticals And Two More Promising Picks

Simply Wall St.

Botanix Pharmaceuticals Buys Back Nearly 7 Million Ordinary Shares

MT Newswires Live

David Allen reveals the systematic playbook behind Plato’s 25 percent returns

Botanix Pharmaceuticals Shareholders Reject Remuneration Report

MT Newswires Live

Botanix Pharmaceuticals Showcases Sofdra Clinical Data at Dermatology Conferences

Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BOT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BOT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BOT.AU\",,,,,undefined,":{"symbol":"BOT.AU","market":"AU","secType":"STK","nameCN":"BOTANIX PHARMACEUTICALS LTD","latestPrice":0.052,"timestamp":1772422366688,"preClose":0.056,"halted":0,"volume":21750351,"delay":0,"changeRate":-0.0714285714285715,"nameEN":"BOTANIX PHARMACEUTICALS LTD","floatShares":1717605114,"shares":2218097000,"eps":-0.046827,"marketStatus":"Trading","change":-0.004,"latestTime":"03-02 14:33:38 AEDT","open":0.056,"high":0.056,"low":0.052,"amount":1177080,"amplitude":0.071429,"askPrice":0.053,"askSize":71046,"bidPrice":0.052,"bidSize":5195027,"shortable":3,"etf":0,"ttmEps":-0.046827,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772427600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.056,"openAndCloseTimeList":[[1772406000000,1772427600000]],"volumeRatio":1.6803,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BOT.AU\",,,,,undefined,":{"symbol":"BOT.AU","floatShares":1717605114,"roa":"-53.68%","roe":"-121.11%","lyrEps":-0.046827,"volumeRatio":1.6803,"shares":2218097000,"dividePrice":0,"high":0.056,"amplitude":0.071429,"preClose":0.056,"low":0.052,"week52Low":0.052,"pbRate":"2.14","psRate":"5.38","week52High":0.485,"institutionHeld":0,"latestPrice":0.052,"committee":0.973017,"eps":-0.046827,"divideRate":0,"volume":21750351,"delay":0,"ttmEps":-0.046827,"open":0.056,"prevYearClose":0.135,"prevWeekClose":0.056,"prevMonthClose":0.056,"prevQuarterClose":0.135,"fiveDayClose":0.059,"twentyDayClose":0.1,"sixtyDayClose":0.125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BOT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614072882","title":"BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614072882","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614072882?lang=en_us&edition=fundamental","pubTime":"2026-02-27 15:57","pubTimestamp":1772179062,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 MillionFeb 27 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:HY LOSS ATTRIBUTABLE A$33.2 MILLIONREVENUE FROM ORDINARY ACTIVITIES FOR HY A$16.5 MILLIONFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM2A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7502","BOT.AU","BK7096"],"gpt_icon":0},{"id":"2614000023","title":"Botanix Pharmaceuticals Ltd - Revenue From Ordinary Activities for Hy a$16.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614000023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614000023?lang=en_us&edition=fundamental","pubTime":"2026-02-27 12:21","pubTimestamp":1772166100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM2A8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BOT.AU","BK7502","BK7508","BK7096"],"gpt_icon":0},{"id":"2614388890","title":"Bank of Thailand Unexpectedly Cuts Rate to 1% in Second Consecutive Easing Measure","url":"https://stock-news.laohu8.com/highlight/detail?id=2614388890","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614388890?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:28","pubTimestamp":1772008080,"startTime":"0","endTime":"0","summary":"TradingKey - The Bank of Thailand (BOT) has lowered its policy rate to 1.00%, the lowest level since September 2022. This marks the institution's second consecutive easing measure aimed at supporting economic recovery and addressing the pain points of sluggish domestic growth and elevated deflationa","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230817/33178b9b092a09cb252a15334d0896f3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230817/33178b9b092a09cb252a15334d0896f3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/economic-indicator/261618327-thailand-bot-interest-rates-thb-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BOT.AU","BK7502","BK7508"],"gpt_icon":0},{"id":"2612413214","title":"A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2612413214","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612413214?lang=en_us&edition=fundamental","pubTime":"2026-02-18 12:44","pubTimestamp":1771389874,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is issuing new ordinary shares at A$0.06 with attached options that could reshape its capital structure.\nSee our latest analysis for Botanix Pharmaceuticals.\nThat equity raising lands after a sharp reset in sentiment, with a 1 day share price return showing a 41.33% decline at the latest A$0.066 close and a 1 year total shareholder return of 86.80%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-after-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-after-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4215","BOT.AU","BK7508","DCF","BK4585","EQR","BK7096","BK7502","BK4588"],"gpt_icon":0},{"id":"2612436270","title":"Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2612436270","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612436270?lang=en_us&edition=fundamental","pubTime":"2026-02-17 10:37","pubTimestamp":1771295855,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals  received firm commitments to raise about  AU$40 million via a two-tranche placement of 666.7 million shares at AU$0.06 per share, according to a Tuesday filing with the Australian bourse.The offer price represents an 45.5% discount to the stock's last traded price before the trading halt on Feb.13, the filing said.Tranche one is expected to raise around AU$14.9 million by issuing 247.9 million shares at the offer price, while tranche two aims to raise about AU$25.1 million through the issue of 418.7 million shares, subject to shareholder approval, the filing added.The company will also allow eligible shareholders to participate in a share purchase plan to raise up to AU$5 million at the same price, the company said.Funds raised will be used towards the purchase of active pharmaceutical ingredient  and costs to obtain a second API supplier, the company added.The new shares are expected to settle in early April.Shares of the company fell 39% in recent Tuesday tra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7502","BK4535","API","BK4023","BK7096","BK4551","BK7103","BK7508","BOT.AU","BK4503","API.AU"],"gpt_icon":0},{"id":"2612403435","title":"BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2612403435","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612403435?lang=en_us&edition=fundamental","pubTime":"2026-02-17 09:23","pubTimestamp":1771291417,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement Feb 17 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:FIRM COMMITMENTS FOR A$40 MILLION TWO-TRANCHE PLACEMENT AT A$0.06 PER NEW SHAREFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7508","BOT.AU","BK7096"],"gpt_icon":0},{"id":"2612438681","title":"Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2612438681","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612438681?lang=en_us&edition=fundamental","pubTime":"2026-02-17 06:43","pubTimestamp":1771281803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BK7508","BOT.AU"],"gpt_icon":0},{"id":"2611152164","title":"Danantara Names Five Chinese Finalists for Waste-to-Energy Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2611152164","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611152164?lang=en_us&edition=fundamental","pubTime":"2026-02-13 16:24","pubTimestamp":1770971068,"startTime":"0","endTime":"0","summary":"TEMPO.CO,Jakarta-A number of companies from China have dominated the selection of winners for the Waste-to-Energy Electricity Generation  project tender managed by Danantara Indonesia. Out of 24 international companies that passed the final selection, five are Chinese corporations now competing to secure initial phase projects across four cities.Lead of Waste-to-Energy at Danantara Indonesia, Fadli Rahman, stated that all participants are required to form a consortium with local partners. \"We hope that the consortium can provide technology transfer to local companies or local governments,\" said Fadli, quoted from a written statement on Friday, February 13, 2026.","market":"nz","thumbnail":"https://statik.tempo.co/data/2022/06/28/id_1121255/1121255_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2022/06/28/id_1121255/1121255_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2086994/danantara-names-five-chinese-finalists-for-waste-to-energy-projects","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2086994/danantara-names-five-chinese-finalists-for-waste-to-energy-projects","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BOT.AU","BK7508","601827","BK7502","BK0218","BK7096"],"gpt_icon":0},{"id":"2611900983","title":"BRIEF-Botanix Pharmaceuticals Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2611900983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611900983?lang=en_us&edition=fundamental","pubTime":"2026-02-13 09:49","pubTimestamp":1770947363,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Requests Trading HaltFeb 13 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:REQUESTS TRADING HALT FOR POTENTIAL CAPITAL RAISINGFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7508","BK7096","BOT.AU"],"gpt_icon":0},{"id":"2611169904","title":"Botanix Pharmaceuticals Ltd - Requests Trading Halt for Potential Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611169904?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:31","pubTimestamp":1770942672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BOT.AU","BK7508"],"gpt_icon":0},{"id":"2610655881","title":"Blue Ocean Technologies Announces Executive Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2610655881","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610655881?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643800,"startTime":"0","endTime":"0","summary":"Appoints Robert Virgilio as Chief Compliance Officer of Blue Ocean ATS & Expands South Korean Team with Addition of Daehyun Kim in new Trade Support Role. Virgilio holds a Bachelor of Science from Niagara University, an MBA from St. John's University, and FINRA Series 4, 7, 9/10, 14, 24, and 57 licenses. He is a past member of the SIFMA Self-Regulation and Supervisory Practices Committee, and NYSE Market Compliance Advisory Committee. Kim holds a Master of Commerce  from the University of Sydney and a Bachelor's/Diploma in Information Technology from Queensland University of Technology. He is a Certified Securities and Derivatives Investment Advisor (Korea Financial Inv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/blue-ocean-technologies-announces-executive-changes-302681886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BOT.AU","ATS","BK4161","NMS","BK7502","BK7096"],"gpt_icon":0},{"id":"2610755505","title":"NetAssist Strengthens SOC Capabilities with Graylog Security","url":"https://stock-news.laohu8.com/highlight/detail?id=2610755505","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610755505?lang=en_us&edition=fundamental","pubTime":"2026-02-09 08:00","pubTimestamp":1770595200,"startTime":"0","endTime":"0","summary":"Delivers Faster Detection and Scalable Operations for Enterprise Customers in Regulated Industries. PETALING JAYA, Malaysia and HOUSTON, Feb. 8, 2026 /PRNewswire/ --NetAssist  Sdn Bhd, a leading Managed Security Services Provider , today announced it has enhanced its security operations using Graylog Security, a modern SIEM platform built to remove the barriers that slow security teams. The deployment enables NetAssist to improve threat detection speed, scale log data processing, and increase operational efficiency for its customers in critical infrastructure, banking, and national payment networks.\"As customer security environments grow more complex, we prioritize technologies that allow us to provide holistic cyber resilience, and through our SOCs, to respond rapidly, scale securely, and deliver outcomes with consistency,\" said Hon Fun Ping, Managing Director of NetAssist. \"Graylog gives us the performance and flexibility to do just that, without compromising on visibility or cost.\".","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/netassist-strengthens-soc-capabilities-with-graylog-security-302681754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC.AU","BK4103","BOT.AU","BK7502","SOC","BK4220","BK4585","BK4588","BK7508","BK7061","BK4213","BK7096"],"gpt_icon":0},{"id":"2608841942","title":"Indonesia Joins Nexus Project to Strengthen Cross-Border Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2608841942","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608841942?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:36","pubTimestamp":1770089771,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-Bank Indonesia  has joined the Nexus project initiated by the Bank for International Settlements , signifying the central bank's commitment to enhance the connectivity of cross-border payment systems.Bank Indonesia will play a role in preparing and implementing the Nexus along with five central banking partners: Bank Negara Malaysia , Bangko Sentral ng Pilipinas , Monetary Authority of Singapore , Bank of Thailand , and Reserve Bank of India .BI Governor Perry Warjiyosaid Indonesia's participation in Nexus serves as a strategic move to provide efficient and affordable cross-border payment solutions for Indonesian people and businesses.","market":"sh","thumbnail":"https://statik.tempo.co/data/2025/11/29/id_1444271/1444271_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/11/29/id_1444271/1444271_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2084658/indonesia-joins-nexus-project-to-strengthen-cross-border-payments","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2084658/indonesia-joins-nexus-project-to-strengthen-cross-border-payments","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["LU1596574779.USD","BK7508","LU1543694498.USD","BK7096","BK7129","BK7502","LU1721427968.SGD","BK4585","LU0170899867.USD","BIS.AU","BIS","LU2413666004.HKD","SG9999001440.SGD","BK4086","BOT.AU","LU2413665964.HKD","LU1620156213.USD","IPS","LU1165135440.EUR","MAS","BK4588","LU1620156130.USD"],"gpt_icon":0},{"id":"2605594394","title":"Botanix Pharmaceuticals Hosts Quarterly Update Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2605594394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605594394?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:12","pubTimestamp":1769055174,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Ltd. will host a Quarterly Update Webinar on Tuesday, 27 January. The event will feature the executive team presenting the Company's Quarterly Activity Report and 4C Quarterly Cash Flow Report. Pre-registration is required for participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Botanix Pharmaceuticals Ltd. published the original content used to generate this news brief on January 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL4rPjrH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7508","BOT.AU","BK7096"],"gpt_icon":0},{"id":"2595281087","title":"ASX Penny Stocks Spotlight: Botanix Pharmaceuticals And Two More Promising Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2595281087","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595281087?lang=en_us&edition=fundamental","pubTime":"2025-12-31 10:05","pubTimestamp":1767146710,"startTime":"0","endTime":"0","summary":"As the Australian market approaches the holiday season, it seems to be winding down with a slight dip of 0.2%, largely attributed to profit-taking as major Wall Street indices near all-time highs. Despite this quiet period, investors may find intriguing opportunities in penny stocks, a term that might seem outdated but still signifies potential growth avenues in smaller or emerging companies. These stocks can offer significant returns when backed by strong financials; let's explore three such...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-vys/vysarn-shares/news/asx-penny-stocks-spotlight-botanix-pharmaceuticals-and-two-m-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-vys/vysarn-shares/news/asx-penny-stocks-spotlight-botanix-pharmaceuticals-and-two-m-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","DSK.AU","AAL.AU","BK7077","BK7143","EZZ.AU","IGL.AU","BK7096","BK7095","BK7132","EDU.AU","BK7111","BK7502","BK7104","MXI.AU","BK7045","MTO.AU","WAF.AU","BK7048","VYS.AU","BOT.AU","BK7055","BK7506","BK7128","BK7094","SSM.AU","BK7050","ONE.AU","VRS.AU"],"gpt_icon":0},{"id":"2595753139","title":"Botanix Pharmaceuticals Buys Back Nearly 7 Million Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595753139","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595753139?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:49","pubTimestamp":1767044955,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals (ASX:BOT) repurchased 6.9 million ordinary, fully-paid shares in an employee share scheme buyback on Monday, according to a Tuesday filing with the Australian bourse.The company did not pay consideration to buy back these shares as it was issued erroneously, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7502","BK7096","BOT.AU","BK7508"],"gpt_icon":0},{"id":"2585082162","title":"David Allen reveals the systematic playbook behind Plato’s 25 percent returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2585082162","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585082162?lang=en_us&edition=fundamental","pubTime":"2025-11-21 09:51","pubTimestamp":1763689870,"startTime":"0","endTime":"0","summary":"Investors love a good story about instinct. The great stock picker who can “feel” when something is about to break higher. The seasoned operator who claims to smell risk before it hits the screens.His edge comes from something far less romantic and far more scalable, a systematic process that can sift through more than 11,000 global companies, flag risks early, and uncover opportunities across growth, value and quality. The results are hard to ignore, since launching in September 2021, the Plato Global Alpha Fund has returned 25 percent per annum, placing it among the best performers in its class.Allen’s philosophy starts with scale. While the MSCI World Index contains roughly 1,300 companies, his investable universe spans more than 11,500. The fund currently holds around 970 long positions and 470 shorts. That sounds like the opposite of traditional stock picking, but scale is an essential ingredient.Some of the fund’s best work comes on the short side, and it is anchored in one eye-c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/david-allen-reveals-the-systematic-playbook-behind-plato-s-25-percent-returns","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/david-allen-reveals-the-systematic-playbook-behind-plato-s-25-percent-returns","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["IE00BDCRKT87.USD","LU2237443978.SGD","IE0034235303.USD","BK4207","LU0211327993.USD","LU2462157665.USD","LU0211326839.USD","LU1894683264.USD","PGA1.AU","IE00BDRTCR15.USD","LU0170899867.USD","BK4588","LU0971096721.USD","LU1496350171.SGD","IE00BYXW3230.USD","BK4504","LU1032466523.USD","IE00B1BXHZ80.USD","LU2242649171.HKD","IE00B3S45H60.SGD","LU0256863811.USD","LU0942090050.USD","LU2592432038.USD","IE00BLSP4239.USD","LU2023250843.SGD","LU2381873111.SGD","BOT.AU","LU2211815571.USD","CBA.AU","LU1496350502.SGD","LU0070302665.USD","BOE.AU","LU0251132253.USD","LU2505996681.GBP","LU2054465674.USD","BK4516","LU1145028129.USD","LU1629891620.HKD","LU0265550946.USD","LU2237443549.SGD","LU0345769128.USD","LU1988902786.USD","LU2264538146.SGD","LU1267930490.SGD","LU1162221912.USD","LU0211328371.USD","LU0238689110.USD","BK7502","LU0265550359.USD","LU0787776722.HKD"],"gpt_icon":0},{"id":"2584901419","title":"Botanix Pharmaceuticals Shareholders Reject Remuneration Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2584901419","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584901419?lang=en_us&edition=fundamental","pubTime":"2025-11-20 12:04","pubTimestamp":1763611462,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals'  shareholders rejected its remuneration report at its annual general meeting on Thursday, according to a same-day Australian bourse filing.Over 73% of the votes cast at the meeting were against the remuneration report.The company's shares rose nearly 2% in recent trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","XKO.AU","XJO.AU","BK7502","XAO.AU","BK7096","BOT.AU"],"gpt_icon":0},{"id":"2582556812","title":"Botanix Pharmaceuticals Showcases Sofdra Clinical Data at Dermatology Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2582556812","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582556812?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:12","pubTimestamp":1762737162,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Ltd. recently announced that three scientific posters related to Sofdra were accepted and exhibited at major dermatology continuing medical education  conferences in October and early November 2025. The posters presented scientific findings to dermatology professionals at these events.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Botanix Pharmaceuticals Ltd. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLbKhq59:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BOT.AU","BK7508","BK7502"],"gpt_icon":0},{"id":"2579186920","title":"Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2579186920","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579186920?lang=en_us&edition=fundamental","pubTime":"2025-10-29 22:40","pubTimestamp":1761748801,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals recently held a special call to update investors on its quarterly activity report and Sofdra® topical gel launch, and is set to present at the 2025 Canaccord Genuity Drug & Device Conference with CEO Howie McKibbon as speaker.\nThese events highlight the company's efforts to communicate operational progress and product momentum to the market at key industry forums.\nWe’ll explore how management’s proactive communication on the Sofdra launch is shaping Botanix...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/will-botanix-pharmaceuticals-asxbot-investor-outreach-reinfo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/will-botanix-pharmaceuticals-asxbot-investor-outreach-reinfo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","BK7502","BK7508","BOT.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}